Theravance Biopharma Submits IBD Drug for FDA Investigational Approval
News
Theravance Biopharma, Inc., a company focused on underserved markets related to infectious diseases, lung and gastrointestinal tract disorders, recently announced in a press release the submission of an investigational new ... Read more